Drugs

Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300

PARIS, FRANCE: EDITION I Demonstrated Similar Blood Sugar Control With Fewer Night-Time Low Blood Sugar Events Compared to Lantus(R) Topline Results of EDITION II Consistent With EDITION I Findings ...

Elan Shareholders Do Not Approve Theravance/Elan Royalty Participation Transaction

SOUTH SAN FRANCISCO, CA: Theravance remains focused on strategy to separate late-stage partnered respiratory assets from biopharmaceutical operations ...

Xylitol Canada Completes Technology Demonstration of Xylose Production Process

TORONTO, ONTARIO: Successful Technological and Economic achievements pave way for commercial production ...

Flamel Technologies Announces Product Partnership Agreement

LYON, FRANCE: ...

Xylitol Canada Inc. Records Significant Revenue Growth

TORONTO, ONTARIO: Acceptance into larger retailers and Club Stores stimulated by increased publicity ...

Judy Murrah Joins Applied DNA Sciences as Chief Information Officer

STONY BROOK, NY: ...

Biologix Hair Inc. Announces Retention of Ottawa-based Launch IR to Direct Investor Relations Activity

TORONTO, ONTARIO: ...

Sirona Biochem Announces LOI for Collaboration with Cincinnati Children's Hospital Medical Center

VANCOUVER, BRITISH COLUMBIA: ...

NuPathe Announces Allowance of Additional U.S. Patent Application for ZECUITY

CONSHOHOCKEN, PA: ...

Theravance to Present at Investor Conferences in June 2013

SOUTH SAN FRANCISCO, CA: ...